Welcome!
SARS
Broker's Calls
Raffles Medical Group upgraded to 'buy' on improved risk-reward: Maybank
Following a share price correction, Maybank Kim Eng Research analyst Lai Gene Lih has upgraded Raffles Medical Group to “buy”.
October 05, 2020
Global review
Residential property prices supported by QE, low interest rates, shrinking supply, says RHB
The Singapore residential property market is probably a lot more resilient during Cov-id-19 than it was either during the Asian Financial Crisis (AFC), SARS or the Global Financial Crisis (GFC). Despite the “circuit breaker” measu
June 12, 2020
Investing ideas
STI components now vs 2003 shows volatility has yet to run its course
SINGAPORE (Feb 10): As of of Feb 5, 28 persons in Singapore have succumbed to the novel coronavirus which originated from Wuhan city in China. And the epidemic is expected to impact the city state’s economy and employment rate, says the government
February 07, 2020
Global Economy
Tourism businesses worldwide brace for a hit worse than SARS
China’s increased affluence and consumption since SARS have made many international cities, luxury brands and retail industry groups more reliant than ever on Chinese travelers.
January 31, 2020
Covid-19
Wuhan coronavirus could be worse for economy than SARS, Singapore among most vulnerable: Nomura
“The worst is yet to come,” Nomura says.
January 29, 2020
This new anti-viral drug could beat Ebola, SARS, H5N1 Avian Bird Flu, and more
SINGAPORE (Feb 28): Singapore eDevelopment (SeD) announced Wednesday that its biomedical subsidiary, Global BioLife Inc., has completed the Zaire Ebola virus research portion for the study of a new anti-viral drug called LB2.
February 28, 2018
Broker's Calls
Which stocks risk getting bitten by Zika?
SINGAPORE (Sept 2): Unsurprisingly, the recent Zika outbreak in Singapore is expected to send shockwaves across local markets, especially with the rapid acceleration of virus cases. The number of infections within the republic stands at 151 as of Thursday
September 02, 2016